Education
About Us
Working with TipRanks
Follow Us
Matthew B. Murphy Insider Profile
4 Followers
Matthew B. Murphy, GC at Nautilus Biotechnolgy, holds 75.39K shares in Nautilus Biotechnolgy (Ticker: NAUT). Most recently, Matthew B. Murphy Bought 20,000 shares of Nautilus Biotechnolgy on Sep 05, 2025 for an estimated value of $12.80K.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-17.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Matthew B. Murphy's holdings
Insider Roles
GC
Roles that Matthew B. Murphy holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Aug 16, 2022 - Aug 16, 2023
Return:+9.80%
The most profitable trade made by Matthew B. Murphy
Matthew B. Murphy's Trading History
List of latest transactions for each holding click on a transaction to see Matthew B. Murphy's performance on stock
You May Also Like
Matthew B. Murphy insider profile FAQ
What is the percentage of profitable transactions made by Matthew B. Murphy?
The percentage of profitable transactions made by Matthew B. Murphy is 33%.
What is the average return per transaction made by Matthew B. Murphy?
The average return per transaction made by Matthew B. Murphy is -17.40%.
What stocks does Matthew B. Murphy hold?
Matthew B. Murphy holds: NAUT stocks.
What was Matthew B. Murphy’s latest transaction?
Matthew B. Murphy latest transaction was an Informative Buy of $12.80K.
What was Matthew B. Murphy's most profitable transaction?
Matthew B. Murphy’s most profitable transaction was an Informative Buy of NAUT stock on August 16, 2022. The return on the trade was 9.80%.
What is Matthew B. Murphy's role in Nautilus Biotechnolgy?
Matthew B. Murphy's role in Nautilus Biotechnolgy is GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.